Nasopharyngeal Carcinoma Clinical Trials in Nanchang, Jiangxi
14 recruitingNanchang, Jiangxi, China
Showing 1–14 of 14 trials
Recruiting
Phase 3
IC Plus Low-dose Radiation Plus Cadonilimab in LANPC
ChemotherapyRadiotherapyImmune Checkpoint Inhibitor+1 more
Sun Yat-sen University380 enrolled3 locationsNCT05941741
Recruiting
Phase 3
Reduced-dose Radiotherapy for Stage III Nasopharyngeal Carcinoma Based on the Treatment Response
Nasopharyngeal Carcinoma
Sun Yat-sen University593 enrolled26 locationsNCT06239727
Recruiting
Phase 2
Induction High-Low Dose Radiotherapy Plus Anti-PD-1 Followed by Definitive Radiotherapy in Recurrent Nasopharyngeal Carcinoma (Single-Arm Phase II)
Nasopharyngeal Carcinoma (NPC)Recurrent Nasopharyngeal Neoplasms
Jiangxi Provincial Cancer Hospital23 enrolled1 locationNCT07277764
Recruiting
Phase 1Phase 2
A Study of YL201 in Combination With Toripalimab and With or Without Cisplatin in Nasopharyngeal Carcinoma.
Recurrent or Metastatic Nasopharyngeal Carcinoma
MediLink Therapeutics (Suzhou) Co., Ltd.202 enrolled20 locationsNCT07258979
Recruiting
Phase 2
A Study of SI-B003 and BL-B01D1+SI-B003 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid Tumors
Non-small Cell Lung CancerNasopharyngeal Carcinoma
Sichuan Baili Pharmaceutical Co., Ltd.121 enrolled16 locationsNCT05956587
Recruiting
Phase 2
Effect of Nutritional Management on Patients With Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma
Nasopharyngeal Carcinoma (NPC)
Jiangxi Provincial Cancer Hospital109 enrolled1 locationNCT07085988
Recruiting
Phase 3
Prophylactic Radiotherapy Optimization for Enhanced Thyroid Function Protection in NPC
Radiotherapy Side EffectQuality of LifeRadiotherapy+2 more
Jiangxi Provincial Cancer Hospital474 enrolled1 locationNCT06752239
Recruiting
Phase 3
Reduced Volume of Neck Prophylactic Irradiation in Nasopharyngeal Carcinoma
Radiotherapy; ComplicationsNasopharyngeal Carcinoma
Sun Yat-sen University474 enrolled7 locationsNCT05780372
Recruiting
Not Applicable
Effect of Immunonutrients on Oral Mucositis in Nasopharyngeal Carcinoma Patients After Chemoradiotherapy
Locally Advanced Nasopharyngeal Carcinoma
First Affiliated Hospital of Guangxi Medical University190 enrolled20 locationsNCT05892354
Recruiting
Phase 2
Anti-PD1 Monoclonal Antibody Combined With Nimotuzumab and Capecitabine in Patients With First-line Platinum-resistant Recurrent/Metastatic Nasopharyngeal Carcinoma
Nasopharyngeal Carcinoma
Jiangxi Provincial Cancer Hospital22 enrolled1 locationNCT06259721
Recruiting
Phase 2
Camrelizumab and Chemotherapy Combined With Endoscopic Surgery for Recurrent Nasopharyngeal Carcinoma
Recurrent Nasopharyngeal Carcinoma
Eye & ENT Hospital of Fudan University100 enrolled7 locationsNCT05011227
Recruiting
The Prognostic Value of the Degree of Pathological Response of Induction Chemotherapy for NPC
Nasopharyngeal CarcinomaTumor MicroenvironmentPathologic Complete Response
Jiangxi Provincial Cancer Hospital300 enrolled1 locationNCT06182657
Recruiting
Phase 2
Transnasal Endoscopic Surgery Combined With Adjuvant Immunotherapy for Recurrent NPC
Recurrent Nasopharyngeal Carcinoma
Eye & ENT Hospital of Fudan University77 enrolled8 locationsNCT05350891
Recruiting
Phase 3
Toripalimab Plus Surgery vs Surgery Alone for Resectable Recurrent Nasopharyngeal Carcinoma
SurgeryNasopharyngeal CarcinomaPD-1
Sun Yat-sen University218 enrolled7 locationsNCT04778956